Observational study on advanced chronic liver diseases in Vienna

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The VICIS study involves patients with advanced chronic liver diseases treated at the Vienna General Hospital. Participants will undergo regular follow-ups and clinical visits, during which clinical and laboratory parameters will be recorded. The study aims to assess the degree of portal hypertension and other related conditions through various diagnostic methods, including HVPG measurement and liver stiffness assessment. Additionally, a biobank will be established to collect biological samples from participants for further research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>18 years and \<100 years
* Diagnosis of advanced chronic liver disease (by liver stiffness ≥10kPa, HVPG\>5mmHg or Histology F3/F4)
* Written informed consent

Exclusion Criteria:

* Withdrawal of written informed consent

Where it's running

• Medical University of Vienna
  Vienna, Austria Recruiting

Study contacts

• Principal investigator: Thomas Reiberger, M.D. — Medical University of Vienna
• Study coordinator: Thomas Reiberger, M.D.
• Email: thomas.reiberger@meduniwien.ac.at
• Phone: +43140400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS

  A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.

  Recruiting Air Force Military Medical University, China · Xi'an, Shaanxi · NCT07799948

• Apixaban plus carvedilol to prevent portal-hypertension complications in cirrhosis

  This will test whether adding apixaban to carvedilol can help prevent variceal bleeding, portal vein thrombosis, and other portal-hypertension complications in adults with Child-Pugh B cirrhosis.

  Recruiting Phase 4 Asian Institute Of Medical Sciences · Hyderābād, Sindh · NCT07521332

• Austrian PBC Registry

  This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.

  Recruiting Medical University of Vienna · Klagenfurt, Carinthia and 10 other locations · NCT07598669

• Blood clotting and portal vein changes during TIPS placement in cirrhosis

  This project will see how blood clotting in the body and in the portal vein changes in adults with cirrhosis who are having a TIPS placed.

  Recruiting Assistance Publique - Hôpitaux de Paris · Villejuif · NCT07439939

• Developing and testing the Liver Cirrhosis Cognitive Decline Scale (LiCCoS)

  This project will test a short questionnaire called LiCCoS to see if it can spot thinking and everyday mental problems in adults with liver cirrhosis.

  Recruiting University of Malaya · Ambāla, Haryana · NCT07418008

• Handgrip strength and portal vein blood flow in people with liver cirrhosis

  This trial will test whether squeezing a handgrip changes portal vein and left gastric vein pressures and blood flow in adults with liver cirrhosis to see if muscle strength affects variceal hemodynamics.

  Recruiting at 2 sites Shanxi Provincial People's Hospital · Luoyang, Henan and 1 other locations · NCT07116096

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.